The Clinicopathologic Features of Molecular Apocrine Breast Cancer
Yoon Jin Cha, Woo-Hee Jung, Ja Seung Koo
Korean J Pathol. 2012;46(2):169-176.   Published online 2012 Apr 25     DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.2.169
Citations to this article as recorded by Crossref logo
The role of histopathologic testing on apocrine carcinoma of the breast
Burak Ilhan, Selman Emiroğlu, Rustu Türkay, Rıdvan Ilhan
Current Problems in Cancer.2020; 44(2): 100501.     CrossRef
Cancer du sein triple négatif exprimant le récepteur aux androgènes : de la biologie à la thérapeutique
Thomas Grellety
Bulletin du Cancer.2020; 107(4): 506.     CrossRef
Triple‐negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple‐negative breast cancers
Cletus A. Arciero, Albert H. Diehl, Yuan Liu, Qin Sun, Theresa Gillespie, Xiaoxian Li, Preeti Subhedar
Journal of Surgical Oncology.2020; 122(6): 1232.     CrossRef
Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast
Clare D'Arcy, Cecily M Quinn
Journal of Clinical Pathology.2019; 72(1): 7.     CrossRef
Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target
Thomas Grellety, Celine Callens, Elodie Richard, Adrien Briaux, Valérie Vélasco, Marina Pulido, Anthony Gonçalves, Pierre Gestraud, Gaetan MacGrogan, Hervé Bonnefoi, Bruno Cardinaud
Clinical Cancer Research.2019; 25(2): 856.     CrossRef
A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience
Denira Imamovic, Nurija Bilalovic, Faruk Skenderi, Vanesa Beslagic, Timur Ceric, Berisa Hasanbegovic, Semir Beslija, Semir Vranic
The Breast Journal.2018; 24(6): 1105.     CrossRef
Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database
Ning Zhang, Hanwen Zhang, Tong Chen, Qifeng Yang
Oncotarget.2017; 8(15): 24579.     CrossRef
Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor–Positive Subset of Triple-Negative Breast Cancers
Anne M. Mills, Chelsea E. Gottlieb, Scott M. Wendroth, Christiana M. Brenin, Kristen A. Atkins
American Journal of Surgical Pathology.2016; 40(8): 1109.     CrossRef
Androgen Receptor: A Complex Therapeutic Target for Breast Cancer
Ramesh Narayanan, James Dalton
Cancers.2016; 8(12): 108.     CrossRef
Early versus late distant metastasis and adjuvant chemotherapy alone versus both radiotherapy and chemotherapy in molecular apocrine breast cancer
Xiaozhen Liu, Yang Yang, Xiaolong Feng, Honghong Shen, Jian Liu, Xia Liu, Yun Niu
Oncotarget.2016; 7(31): 48905.     CrossRef
Molecular and diagnostic features of apocrine breast lesions
Pavel Gromov, Jaime A Espinoza, Irina Gromova
Expert Review of Molecular Diagnostics.2015; 15(8): 1011.     CrossRef
Prevalencia de receptores androgénicos en el cáncer de mama
Claudia Janeth Rodríguez-Silva, José Luis González-Vela, Ascary Alcides Velázquez-Pacheco
Gaceta Mexicana de Oncología.2015; 14(3): 135.     CrossRef